ALB and hepatocellular carcinoma: Studies conducted by Luo et al. [111], Lu et al. [112], Wu et al. [113], and Pang et al. [114] showed that a high pre-treatment serum PLT–ALB–BIL grade independently predicted worse OS and RFS in HCC patients undergoing curative surgical resection.